Net margin · 2016–2025
Corcept Therapeutics net margin
13.1%−37.4% · FY2025
Corcept Therapeutics (CORT) reported 13.1% in net margin for fiscal 2025, −37.4% year on year.
| Fiscal year | Net margin | Change | Filing |
|---|---|---|---|
| FY2025 | 13.1% | −37.4% | Derived |
| FY2024 | 20.9% | −4.9% | Derived |
| FY2023 | 22.0% | −12.8% | Derived |
| FY2022 | 25.2% | −17.9% | Derived |
| FY2021 | 30.7% | +2.6% | Derived |
| FY2020 | 30.0% | −2.5% | Derived |
| FY2019 | 30.7% | +2.4% | Derived |
| FY2018 | 30.0% | −63.0% | Derived |
| FY2017 | 81.1% | +710.3% | Derived |
| FY2016 | 10.0% | — | Derived |
Net margin — Net margin is net income divided by revenue. Only companies with at least $1 billion in revenue are ranked here: a small company can post an extreme margin that tells you nothing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +3.0%
Calculated from two reported figures, so it has no single filing of its own.
Net margin at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Corcept Therapeutics net margin |url=https://companiesranked.com/en/company/corcept-therapeutics/net-profit-margin |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Corcept Therapeutics net margin. CompaniesRanked. https://companiesranked.com/en/company/corcept-therapeutics/net-profit-marginBibTeX
@misc{companiesranked-en-company-corcept-therapeutics-net-profit-margin-2026,
author = {{CompaniesRanked}},
title = {{Corcept Therapeutics net margin}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/corcept-therapeutics/net-profit-margin}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.